Early malignant progression of hereditary medullary thyroid cancer. - Wikidata - wikimedia - TriplyDB

Early malignant progression of hereditary medullary thyroid cancer.

Early malignant progression of hereditary medullary thyroid cancer.

http://www.wikidata.org/entity/Q30320549

about

Next generation sequencing in endocrine practice Multiple endocrine neoplasia type 2: achievements and current challenges Multiple endocrine neoplasia type 2: an overview RET gene abnormalities and thyroid disease: who should be screened and when Variability in Penetrance of Multiple Endocrine Neoplasia 2A with Amino Acid Substitutions in RET Codon 634.German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors.Germline RET sequence variation I852M and occult medullary thyroid cancer: harmless polymorphism or causative mutation?Familial prevalence and age of RET germline mutations: implications for screening.Age-related penetrance of endocrine tumours in multiple endocrine neoplasia type 1 (MEN1): a multicentre study of 258 gene carriers.Multiple endocrine neoplasia type 2 kindred with novel tandem RET mutations: Case report with an applied in silico mutational tolerance analysis.American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers Somatic VHL gene alterations in MEN2-associated medullary thyroid carcinoma.Medullary thyroid carcinoma: targeted therapies and future directions Pathogenicity of DNA variants and double mutations in multiple endocrine neoplasia type 2 and von Hippel-Lindau syndrome.Multiple endocrine neoplasia type 2 and familial medullary thyroid carcinoma: an update Medullary thyroid cancer: monitoring and therapy.Factors predicting outcome of total thyroidectomy in young patients with multiple endocrine neoplasia type 2: a nationwide long-term follow-up study.Thyroid cancer: current molecular perspectives.An introduction to managing medullary thyroid cancer Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.Multiple endocrine neoplasia type 2B with a RET proto-oncogene A883F mutation displays a more indolent form of medullary thyroid carcinoma compared with a RET M918T mutation BAY 43-9006 inhibition of oncogenic RET mutants.Medullary thyroid carcinoma: surgical treatment advances.Clinical review: Incidentally discovered medullary thyroid cancer: diagnostic strategies and treatment Predominant RET Germline Mutations in Exons 10, 11, and 16 in Iranian Patients with Hereditary Medullary Thyroid Carcinoma.The oncogenic activity of RET point mutants for follicular thyroid cells may account for the occurrence of papillary thyroid carcinoma in patients affected by familial medullary thyroid carcinoma.Identification of occult metastases of medullary thyroid carcinoma by pentagastrin-stimulated intravenous calcitonin sampling followed by targeted surgery.Genotype-phenotype correlation in multiple endocrine neoplasia type 2 Multiple endocrine neoplasia: the Chilean experience.Correlation between Calcitonin Levels and [(18)F]FDG-PET/CT in the Detection of Recurrence in Patients with Sporadic and Hereditary Medullary Thyroid Cancer Advances in the management of hereditary medullary thyroid cancer.Counselling in multiple endocrine neoplasia syndromes: from individual experience to general guidelines.Molecular genetics of multiple endocrine neoplasia types 1 and 2.Postoperative Complications After Prophylactic Thyroidectomy for Very Young Patients With Multiple Endocrine Neoplasia Type 2: Retrospective Cohort Analysis.MicroRNA profiles in familial and sporadic medullary thyroid carcinoma: preliminary relationships with RET status and outcome A Case of medullary thyroid carcinoma with de novo V804M RET germline mutation Hereditary medullary thyroid cancer: age-appropriate thyroidectomy improves disease-free survival.Current approaches to medullary thyroid carcinoma, sporadic and familial.Management of the Parathyroid Glands During Preventive Thyroidectomy in Patients With Multiple Endocrine Neoplasia Type 2 Distribution of RET Mutations and Evaluation of Treatment Approaches in Hereditary Medullary Thyroid Carcinoma in Turkey.

P2860

Q26997391-B9491EC3-6D34-436B-BEC5-B62EF950A58F Q27024073-6DFDAA9F-0C09-49A0-8F28-B425C2838BDC Q28237010-50B2993D-D87C-4CF9-B9FC-AAAE1E4547F6 Q28709562-16FFE5AE-E0C0-44E1-83CE-D0F81B7C686E Q30315963-3685CCEA-699F-403A-A5D4-F93F19A0850A Q30317867-63A06597-1844-4972-8211-6B48F1ACA41C Q30318368-44AAD1B1-0CE8-45DF-8B63-8AF1A5B5F1E9 Q30319713-55624869-85C6-4AC5-8B5F-EE0AA83E52CF Q30319804-DAFEE379-0ED8-4BE5-A613-2F1CAA103405 Q30384468-0B4299E3-4C9F-4E95-BB70-5B557C463BD8 Q30416965-C77C638A-AAAC-4634-BAD6-3530CB48538C Q33243796-3A17EA79-F674-45D6-A6FC-684018AD20B4 Q33557376-894FBC9F-A468-4282-BF63-209A284EE41A Q33586709-75F46AD5-86FC-46FB-9D02-1E4C35FD000F Q33587821-7900307D-9781-4120-ABF7-81886275FA84 Q33591999-4A5F62F2-D57B-4EE9-A207-74A74B5F3F0C Q33706700-DC459F8F-697C-413A-A2D4-7CF1F7A535F2 Q33760910-F834EFF1-41DD-4D25-9D4B-78BE7E26D97E Q34254131-8E596DD8-1248-4FD3-B71C-FD780A0E7FE0 Q34468665-8173A898-F946-4525-9E66-4B3EBB4F967D Q34511708-A4B12016-1C87-4DE8-938A-53903B332D23 Q34565246-EAF02430-4E0C-4041-91B3-B5784DDEE6ED Q34635409-CD23C580-6826-4919-A60E-EF770BDDBD3F Q34894198-DE8D1632-5DA1-4F7D-B697-676E785E9E73 Q35098936-45DE9453-6EAD-404C-86D0-9EC6E9BEE784 Q35103009-03EDEB99-D7A7-4471-8EC5-8D8128F6828A Q35768791-A3EB743B-4048-4EBA-9139-034F02DFCEE6 Q35895489-55DF6E70-E996-46AE-8C26-AD037B242AE1 Q35895498-82505A1A-6AFC-46AA-A661-3D1F40778618 Q35979079-E0A76869-A291-47D6-A4FF-71A91BF23B75 Q35987850-FC85DB00-D579-4EFE-A1B7-D885DC9A4EDB Q35987860-0604240D-EAAD-4165-BE0E-FF8F31CE37A2 Q36111935-A96589BF-24EB-4309-9125-69AB1352BF3E Q36153645-BB8B282E-8B03-4BB6-8AB2-8BAE3577098F Q36194110-EDE9308A-4B35-4D09-BD62-1B53DCD57BF4 Q36536295-4B88CBCD-8AEF-4ADF-BE89-76A9DF39EC44 Q36652843-1AD21CA8-875A-4C21-9E18-C63F6C3245E1 Q36666674-16D0192F-2FBE-4C59-A0BA-43CBFFBA0864 Q36696653-CC7A8F76-7863-4FD2-90A3-4F22696AE9A6 Q36722002-D3FAEFB1-8D6A-4F11-8CD5-B6C8A1F816BB

P2860

Early malignant progression of hereditary medullary thyroid cancer.

http://www.wikidata.org/entity/Q30320549

description

2003 nî lūn-bûn

@nan

2003 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Early malignant progression of hereditary medullary thyroid cancer.

@ast

Early malignant progression of hereditary medullary thyroid cancer.

@en

type

label

Early malignant progression of hereditary medullary thyroid cancer.

@ast

Early malignant progression of hereditary medullary thyroid cancer.

@en

prefLabel

Early malignant progression of hereditary medullary thyroid cancer.

@ast

Early malignant progression of hereditary medullary thyroid cancer.

@en

P1433

Q30320549-7700E3B9-2E1C-49A2-B3AE-745E2691D6EC

P1476

Q30320549-9E194048-CB0D-4321-9C1E-8F65C680E1DD

P2093

Q30320549-007E4EAE-333F-43C7-ABEA-85BB13C11BF3

Q30320549-442D0A3A-1C48-4258-8F6B-6B6D8563209C

Q30320549-47058C47-8081-4FB4-B996-630C5592DDE0

Q30320549-66EDD2E7-9558-478F-837C-F12CA415B689

Q30320549-7D73FD46-EBFD-447D-99B5-84EB3E36DACB

Q30320549-952FDE8A-7769-4637-B126-55AD57E73DF7

Q30320549-A42E3883-6D44-4A3B-AA7F-EBB9C58CFB08

Q30320549-B0047738-C807-499C-A97A-B53E0E17501C

Q30320549-B11B182E-ED09-4513-94A4-4C5AA7D81FAF

Q30320549-E692BF57-5CF9-46B2-A19E-ED9B0E461990

P304

Q30320549-3E9FD88F-5120-4065-87EF-8DE1C2F375D4

P31

Q30320549-1EB77330-E2EA-4A56-94AB-D93E34780918

P356

Q30320549-B4DE28A1-F57D-479B-86BF-D2A1970D67A2

P407

Q30320549-DA8B8CC7-070D-4ABC-B455-0C247FDEAAC9

P433

Q30320549-CDBFC4AE-735C-4E19-9DAC-337B74722061

P478

Q30320549-ED1B2CC7-6229-4DFE-9F11-D9910868FA7F

P50

Q30320549-59ADC15A-9FD1-4516-ABED-55C7FA844BDF

P577

Q30320549-D558C519-4D85-4C50-913A-543D0C79E6C3

P698

Q30320549-AC687D22-28A8-4FD7-B775-46E122103E35

P356

P1433

The New England Journal of Medicine

P1476

Early malignant progression of hereditary medullary thyroid cancer.

@en

P2093

Andreas Machens

http://www.w3.org/2001/XMLSchema#string

Bernard Conte-Devolx

http://www.w3.org/2001/XMLSchema#string

European Multiple Endocrine Neoplasia (EUROMEN) Study Group

http://www.w3.org/2001/XMLSchema#string

Friedhelm Raue

http://www.w3.org/2001/XMLSchema#string

Hans-Dietrich Roeher

http://www.w3.org/2001/XMLSchema#string

Josef Hoegel

http://www.w3.org/2001/XMLSchema#string

Karin Frank-Raue

http://www.w3.org/2001/XMLSchema#string

Patricia Niccoli-Sire

http://www.w3.org/2001/XMLSchema#string

Peter Lamesch

http://www.w3.org/2001/XMLSchema#string

Robert A Wahl

http://www.w3.org/2001/XMLSchema#string

P304

1517-1525

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA012915

http://www.w3.org/2001/XMLSchema#string

P407

P433

16

http://www.w3.org/2001/XMLSchema#string

P478

349

http://www.w3.org/2001/XMLSchema#string

P50

P577

2003-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14561794

http://www.w3.org/2001/XMLSchema#string